Research Solutions (RSSS) Cash & Equivalents (2010 - 2026)

Research Solutions (RSSS) has 17 years of Cash & Equivalents data on file, last reported at $12.1 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 22.31% year-over-year to $12.1 million in Q1 2026; TTM through Mar 2026 was $12.1 million, a 22.31% increase from a year earlier, with the FY2025 full-year figure at $12.2 million, up 100.45% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $12.1 million, down from $12.3 million in the prior quarter.
• Over the last five years, Cash & Equivalents for RSSS reached as high as $13.5 million in Q2 2023 and fell as low as $2.7 million in Q4 2023.
• Historically, Cash & Equivalents has averaged $9.7 million across 5 years, with a median of $10.6 million in 2022.
• Across the five-year window, Cash & Equivalents sank 76.05% in 2023 and jumped 185.48% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $11.3 million in 2022, then sank by 76.05% to $2.7 million in 2023, then soared by 185.48% to $7.7 million in 2024, then surged by 59.23% to $12.3 million in 2025, then declined by 1.73% to $12.1 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $12.1 million in Q1 2026, $12.3 million in Q4 2025, and $12.0 million in Q3 2025.